TriSalus Life Sciences Operating Margin Growth & History (TLSI)
TriSalus Life Sciences's operating margin was −59.68% for fiscal 2025.
View full TriSalus Life Sciences company overviewTriSalus Life Sciences annual operating margin history
2022
2023
2024
2025
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −59.68% | +63.20 pp |
| 2024 | 2024-12-31 | −122.88% | +171.40 pp |
| 2023 | 2023-12-31 | −294.28% | −0.37 pp |
| 2022 | 2022-12-31 | −293.91% | — |
TriSalus Life Sciences quarterly operating margin
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −86.03% | −20.64 pp |
| Q1 2026 | 2026-03-31 | −94.52% | −14.57 pp |
| Q4 2025 | 2025-12-31 | −24.77% | +66.99 pp |
| Q3 2025 | 2025-09-30 | −77.94% | +40.98 pp |
| Q2 2025 | 2025-06-30 | −65.39% | +45.61 pp |
| Q1 2025 | 2025-03-31 | −79.95% | +100.82 pp |
| Q4 2024 | 2024-12-31 | −91.76% | +158.23 pp |
| Q3 2024 | 2024-09-30 | −118.91% | +239.57 pp |
| Q2 2024 | 2024-06-30 | −111.00% | +136.92 pp |
| Q1 2024 | 2024-03-31 | −180.77% | +158.41 pp |
| Q4 2023 | 2023-12-31 | −249.98% | — |
| Q3 2023 | 2023-09-30 | −358.48% | −151.73 pp |
| Q2 2023 | 2023-06-30 | −247.92% | — |
| Q1 2023 | 2023-03-31 | −339.18% | — |
| Q3 2022 | 2022-09-30 | −206.76% | — |
TriSalus Life Sciences operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, TriSalus Life Sciences's operating margin increased from −293.91% to −59.68%, a change of +234.23 percentage points. The latest reported quarter, Q2 2026, shows −86.03%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TriSalus Life Sciences source filings ↗